Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progression”

3,508 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,508 results

Testing effectiveness (Phase 2)Study completedNCT01259869
What this trial is testing

PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression

Who this might be right for
Glioblastoma
NCIC Clinical Trials Group 34
Testing effectiveness (Phase 2)Looking for participantsNCT06927180
What this trial is testing

SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Henan Cancer Hospital 180
Not applicableUnknownNCT03175146
What this trial is testing

See Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver Safely

Who this might be right for
Colonic NeoplasmsNeoplasm Metastasis
AHS Cancer Control Alberta 30
Not applicableStudy completedNCT05169827
What this trial is testing

Cerebral Contributions to Symptom Progression in PD

Who this might be right for
Parkinson Disease
Radboud University Medical Center 115
Not applicableEnded earlyNCT01828255
What this trial is testing

Intraocular Pressure (IOP) Patterns in Fast Versus Slow Visual Field (VF) Progression Patients

Who this might be right for
Primary Open-angle Glaucoma (POAG) Patient
Sensimed AG 40
Not applicableStudy completedNCT02392078
What this trial is testing

Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System

Who this might be right for
Metastatic Brain TumorPrimary Brain TumorEpileptic/Seizure Foci+1 more
Monteris Medical 1,153
Not applicableStudy completedNCT01682382
What this trial is testing

Association of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular (CNV)

Who this might be right for
Age-related Macular DegenerationChoroidal Neovascular Age-related Macular Degeneration
Sequenom, Inc. 45
Testing effectiveness (Phase 2)Ended earlyNCT00595985
What this trial is testing

Sorafenib as a Second Line Treatment in Patients With Advanced or Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Fudan University 5
Not applicableUnknownNCT01269580
What this trial is testing

Diabetic Foot and Vascular Progenitor Cells

Who this might be right for
DiabetesCritical Limb Ischemia
IRCCS Multimedica 122
Testing effectiveness (Phase 2)WithdrawnNCT04729296
What this trial is testing

Anti-TNFα to Delay or Prevent Progression to Stage 3 T1D

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Testing effectiveness (Phase 2)Study completedNCT03436862
What this trial is testing

Nivolumab Maintenance Therapy After Autologous Stem Cell Transplant in Hodgkin Lymphoma Pts at Relapse/Progression Risk

Who this might be right for
Hodgkin Lymphoma
SCRI Development Innovations, LLC 37
Not applicableNot Yet RecruitingNCT06875297
What this trial is testing

A Single-center Prospective Interventional Study on FPG500 in Non-metastatic Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 184
Not applicableStudy completedNCT01923103
What this trial is testing

Natural Disease Progress of Dupuytren Disease

Who this might be right for
Dupuytren ContractureDisease Progression
University Medical Center Groningen 261
Testing effectiveness (Phase 2)Looking for participantsNCT05104983
What this trial is testing

Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study

Who this might be right for
Tuberous Sclerosis ComplexEpilepsy
Darcy Krueger 64
Not applicableNot Yet RecruitingNCT07373405
What this trial is testing

Online Interventions to Prevent Alcohol Use Disorders

Who this might be right for
Alcohol Use Disorder (AUD)
University of Southern Denmark 3,519
Not applicableNot Yet RecruitingNCT07116902
What this trial is testing

Artificial Intelligence-based Methods to Predict Disease Progression in Youth With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
University of California, San Francisco 50
Not applicableStudy completedNCT01425957
What this trial is testing

Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment

Who this might be right for
MILD COGNITIVE IMPAIRMENT
Qualissima 229
Testing effectiveness (Phase 2)Looking for participantsNCT06180356
What this trial is testing

Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression

Who this might be right for
Ovarian CancerOligometastatic DiseaseSerous Ovarian Tumor
MedSIR 30
Testing effectiveness (Phase 2)WithdrawnNCT05007769
What this trial is testing

Ramucirumab, Atezolizumab and N-803 After Progression on Any Immune Checkpoint Blocker in NSCLC

Who this might be right for
Non-small Cell Lung CancerNon-small Cell CarcinomaNSCLC+1 more
Washington University School of Medicine
Post-approval studies (Phase 4)UnknownNCT02483169
What this trial is testing

PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study

Who this might be right for
Brain IschemiaIntracranial Hemorrhages
Asan Medical Center 800
Load More Results